|
Supplier News Breaks Archives Lannett Co. has received Food and Drug Administration approval for its 505(b)(2) New Drug Application (NDA) for morphine sulfate oral solution. Former Unilever executive Michael Polk has been appointed president and chief executive officer at Newell Rubbermaid. In the wake of a court decision, Mylan Inc. plans to roll out enteric-coated budesonide capsules, a medication for Crohn's disease. Under a partnership, Centrix Pharmaceutical Inc. plans to promote CutisPharma Inc.'s FIRST Progesterone VGS vaginal suppository compounding kits. Dr. Reddy's Laboratories this week began shipping levofloxacin tablets in the U.S. market after receiving Food and Drug Administration approval for the antibiotic medication. The ReStore! Energy diabetes energy formula from Diabetica Research Solutions Inc. (DRSI) is now available at Publix Super Markets Inc. pharmacies. PNI Digital Media has extended its online photo services contract with CVS/pharmacy. Clearasil said it's taking a fresh marketing angle to reach young consumers with the launch of its "Rock Your Skin" summer campaign. Merck is working with rock musician Gregg Allman and the American Liver Foundation on Tune In to Hep C, a public health campaign to help raise awareness of chronic hepatitis C virus infection. Pfizer Inc. and Acura Pharmaceuticals Inc. have received approval from the Food and Drug Administration to market the pain reliever Oxecta Tablets CII. L'Oréal USA plans to launch the first beauty iAd for iPad with a campaign for L'Oréal Paris later this month. Colgate-Palmolive Co. has closed its purchase of the Sanex personal care brand from Unilever PLC. Physicians Formula Holdings Inc. has developed a new skin care line that later this summer will be carried exclusively at Walmart.
|
